3/20/2023  4:59:31 PM Chg. +2.90 Volume Bid5:10:00 PM Ask5:10:00 PM Market Capitalization Dividend Y. P/E Ratio
341.40DKK +0.86% 610,353
Turnover: 208.77 mill.
341.70Bid Size: 108 341.80Ask Size: 176 77.93 bill.DKK 1.61% 30.16

Business description

Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.

Management board & Supervisory board

Ester Baiget
Management board
Lars Green, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø
Supervisory board
Jørgen Buhl Rasmussen, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James

Company data

Name: Novozymes A.S
Address: Krogshoejvej 36,DK-2880 Bagsvaerd
Phone: +45-44-460000
Fax: -
E-mail: -
Internet: www.novozymes.com/
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 74.50%
IPO date: 11/20/2000

Investor relations

Name: Tobias Cornelius Björklund
IR phone: +45-3077-8682
IR Fax: -
IR e-mail: NovozymesIR@novozymes.com

Company calendar

CW 17 | 4/26/2023 Interim Report 1st Quarter/3 Months
CW 17 | 4/27/2023 Interim Report 1st Quarter/3 Months
CW 32 | 8/9/2023 Interim Report 2nd Quarter/6 Months
CW 32 | 8/11/2023 Interim Report 2nd Quarter/6 Months
CW 43 | 10/26/2023 Interim Report 3rd Quarter/9 Months

Main Shareholders

Novo Holdings A/S